Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Karuna Therapeutics (KRTX) News Today

Karuna Therapeutics logo
Bristol Myers to Purchase Karuna
Karuna Therapeutics, Inc. stock logo
China Universal Asset Management Co. Ltd. Purchases 3,392 Shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX)
China Universal Asset Management Co. Ltd. grew its position in shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX - Free Report) by 349.3% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 4,363 shares of the company's stock after acquiring an additional 3,392 sh
Karuna Therapeutics, Inc. stock logo
Karuna Therapeutics, Inc. (NASDAQ:KRTX) Given Average Rating of "Hold" by Analysts
Karuna Therapeutics, Inc. (NASDAQ:KRTX - Get Free Report) has been assigned an average recommendation of "Hold" from the sixteen ratings firms that are covering the stock, Marketbeat reports. Ten investment analysts have rated the stock with a hold recommendation and six have issued a buy recommen
Karuna Therapeutics, Inc. stock logo
Karuna Therapeutics, Inc. (NASDAQ:KRTX) Stock Position Raised by SG Americas Securities LLC
SG Americas Securities LLC raised its position in shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX - Free Report) by 2,482.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 174,193 shares of the com
Karuna Therapeutics, Inc. stock logo
Deutsche Bank AG Buys 7,282 Shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX)
Deutsche Bank AG raised its holdings in shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX - Free Report) by 16.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 51,584 shares of the company's stock after acquiring a
Karuna Therapeutics, Inc. stock logo
Karuna Therapeutics (NASDAQ:KRTX) Given Neutral Rating at HC Wainwright
HC Wainwright restated a "neutral" rating and issued a $330.00 price target on shares of Karuna Therapeutics in a research report on Thursday.
Karuna Therapeutics, Inc. stock logo
Karuna Therapeutics (NASDAQ:KRTX) Sets New 1-Year High at $329.99
Karuna Therapeutics (NASDAQ:KRTX) Reaches New 12-Month High at $329.99
Karuna Therapeutics, Inc. stock logo
Karuna Therapeutics, Inc. (NASDAQ:KRTX) Sees Significant Decrease in Short Interest
Karuna Therapeutics, Inc. (NASDAQ:KRTX - Get Free Report) was the target of a large decline in short interest in February. As of February 29th, there was short interest totalling 1,970,000 shares, a decline of 6.6% from the February 14th total of 2,110,000 shares. Based on an average daily volume of 858,500 shares, the days-to-cover ratio is presently 2.3 days.
Karuna Therapeutics, Inc. stock logo
Q1 2024 EPS Estimates for Karuna Therapeutics, Inc. (NASDAQ:KRTX) Reduced by Zacks Research
Karuna Therapeutics, Inc. (NASDAQ:KRTX - Free Report) - Zacks Research decreased their Q1 2024 earnings estimates for shares of Karuna Therapeutics in a research report issued to clients and investors on Wednesday, March 13th. Zacks Research analyst R. Department now expects that the company will
Karuna Therapeutics, Inc. stock logo
Hudson Bay Capital Management LP Takes Position in Karuna Therapeutics, Inc. (NASDAQ:KRTX)
Hudson Bay Capital Management LP acquired a new position in shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX - Free Report) in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 20,000 shares of the company's stock, valued at approximately
Karuna Therapeutics, Inc. stock logo
Catalyst Private Wealth LLC Grows Stock Position in Karuna Therapeutics, Inc. (NASDAQ:KRTX)
Catalyst Private Wealth LLC lifted its position in Karuna Therapeutics, Inc. (NASDAQ:KRTX - Free Report) by 256.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 77,855 shares of the company's sto
Karuna Therapeutics, Inc. stock logo
Zacks Research Weighs in on Karuna Therapeutics, Inc.'s FY2026 Earnings (NASDAQ:KRTX)
Karuna Therapeutics, Inc. (NASDAQ:KRTX - Free Report) - Stock analysts at Zacks Research issued their FY2026 EPS estimates for shares of Karuna Therapeutics in a report released on Wednesday, March 13th. Zacks Research analyst R. Department anticipates that the company will earn ($4.32) per share
KRTX May 2024 210.000 call
Karuna Therapeutics, Inc. stock logo
Karuna Therapeutics (NASDAQ:KRTX) Hits New 1-Year High at $321.80
Karuna Therapeutics (NASDAQ:KRTX) Reaches New 52-Week High at $321.80
Karuna Therapeutics, Inc. stock logo
Envestnet Asset Management Inc. Has $3.41 Million Stock Holdings in Karuna Therapeutics, Inc. (NASDAQ:KRTX)
Envestnet Asset Management Inc. increased its position in shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX - Free Report) by 157.5% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 20,18
Karuna Therapeutics, Inc. stock logo
Northern Trust Corp Raises Holdings in Karuna Therapeutics, Inc. (NASDAQ:KRTX)
Northern Trust Corp grew its position in shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX - Free Report) by 9.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 157,561 shares of the company's stock after buying an addi
Karuna Therapeutics, Inc. stock logo
Hsbc Holdings PLC Makes New $2.03 Million Investment in Karuna Therapeutics, Inc. (NASDAQ:KRTX)
Hsbc Holdings PLC acquired a new position in shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX - Free Report) during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund acquired 12,000 shares of the company's stock, valued at approximately $2,029,000. Several other hedge
Karuna Therapeutics, Inc. stock logo
Avidity Partners Management LP Sells 155,500 Shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX)
Avidity Partners Management LP cut its holdings in shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX - Free Report) by 35.2% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 286,700 shares of the company's stock after sel
Karuna Therapeutics, Inc. stock logo
Invesco Ltd. Cuts Holdings in Karuna Therapeutics, Inc. (NASDAQ:KRTX)
Invesco Ltd. reduced its position in Karuna Therapeutics, Inc. (NASDAQ:KRTX - Free Report) by 7.7% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 365,134 shares of the company's stock after selling 30,423 shares during the period. Invesco Ltd. owned about 0.97%
Karuna Therapeutics, Inc. stock logo
Connor Clark & Lunn Investment Management Ltd. Increases Stock Position in Karuna Therapeutics, Inc. (NASDAQ:KRTX)
Connor Clark & Lunn Investment Management Ltd. lifted its holdings in Karuna Therapeutics, Inc. (NASDAQ:KRTX - Free Report) by 25.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 52,690 shares of the company's sto
Karuna Therapeutics, Inc. stock logo
Karuna Therapeutics (NASDAQ:KRTX) Releases Earnings Results, Misses Estimates By $0.36 EPS
Karuna Therapeutics (NASDAQ:KRTX - Get Free Report) announced its earnings results on Thursday. The company reported ($3.01) earnings per share for the quarter, missing analysts' consensus estimates of ($2.65) by ($0.36). The company's revenue for the quarter was down 100.0% on a year-over-year basis. During the same period in the prior year, the company posted ($2.22) earnings per share.
1KRTX : Karuna Therapeutics: Q4 Earnings Insights
Karuna Therapeutics, Inc. stock logo
Aigen Investment Management LP Acquires Shares of 2,275 Karuna Therapeutics, Inc. (NASDAQ:KRTX)
Aigen Investment Management LP acquired a new stake in Karuna Therapeutics, Inc. (NASDAQ:KRTX - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,275 shares of the
Karuna Therapeutics, Inc. stock logo
Deutsche Bank AG Increases Stock Holdings in Karuna Therapeutics, Inc. (NASDAQ:KRTX)
Deutsche Bank AG raised its position in shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX - Free Report) by 16.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 51,584 shares of the company's stock afte
Karuna Therapeutics, Inc. stock logo
Mutual of America Capital Management LLC Has $1.29 Million Holdings in Karuna Therapeutics, Inc. (NASDAQ:KRTX)
Mutual of America Capital Management LLC cut its position in Karuna Therapeutics, Inc. (NASDAQ:KRTX - Free Report) by 52.7% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 7,646 shares of the company's stock after selling 8,535 shares duri
Karuna Therapeutics, Inc. stock logo
Charles Schwab Investment Management Inc. Acquires 32,548 Shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX)
Charles Schwab Investment Management Inc. increased its holdings in shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX - Free Report) by 17.5% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor
Karuna Therapeutics: Getting Sold Short
Karuna Therapeutics, Inc. stock logo
Fmr LLC Acquires 33,579 Shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX)
Fmr LLC grew its position in Karuna Therapeutics, Inc. (NASDAQ:KRTX - Free Report) by 0.6% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,650,167 shares of the company's stock after acquiring an additi
KRTX Mar 2024 320.000 call
KRTX Mar 2024 260.000 put
KRTX Mar 2024 330.000 call
KRTX Mar 2024 280.000 put
Karuna Therapeutics, Inc. stock logo
Short Interest in Karuna Therapeutics, Inc. (NASDAQ:KRTX) Increases By 15.8%
Karuna Therapeutics, Inc. (NASDAQ:KRTX - Get Free Report) was the target of a large increase in short interest in January. As of January 31st, there was short interest totalling 1,690,000 shares, an increase of 15.8% from the January 15th total of 1,460,000 shares. Based on an average daily volume of 820,100 shares, the short-interest ratio is presently 2.1 days.
Karuna Therapeutics, Inc. stock logo
Karuna Therapeutics, Inc. (NASDAQ:KRTX) Shares Sold by Victory Capital Management Inc.
Victory Capital Management Inc. decreased its holdings in Karuna Therapeutics, Inc. (NASDAQ:KRTX - Free Report) by 42.6% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,560 shares of the company's stock after selling 2,645
Get Karuna Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for KRTX and its competitors with MarketBeat's FREE daily newsletter.

Urgent: This election is rigged (Ad)

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

KRTX Media Mentions By Week

KRTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

KRTX
News Sentiment

0.00

0.40

Average
Medical
News Sentiment

KRTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

KRTX Articles
This Week

0

2

KRTX Articles
Average Week

Get Karuna Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for KRTX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:KRTX) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners